Minoru Kamakura

Title: Minoru Kamakura: Innovator in Pharmaceutical Technology

Introduction

Minoru Kamakura is a notable inventor based in Omiya, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug formulations. With a total of 2 patents to his name, Kamakura's work has had a meaningful impact on medication delivery systems.

Latest Patents

Kamakura's latest patents include a sustained-release theophylline tablet and a cation exchange resin preparation. The sustained-release theophylline tablet is designed by coating core granules primarily composed of theophylline with a hydrophobic material and a plastic excipient. This formulation may also include an enteric polymer material to create coated granules, which are then compressed with a disintegrating excipient. The cation exchange resin preparation, on the other hand, is presented in the form of dry syrups. It consists of a cation exchange resin, such as polystyrene calcium sulfonate, combined with a gelling agent like carboxymethylcellulose sodium (CMC-Na). This preparation enhances the oral administration experience by reducing the sandy feel in the mouth and throat, thereby improving taste and ease of use.

Career Highlights

Kamakura is currently associated with Nikken Chemicals Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations to enhance patient compliance and therapeutic efficacy.

Collaborations

Some of Kamakura's notable coworkers include Hiromi Imai and Mutsuo Okumura. Their collaborative efforts contribute to the advancement of pharmaceutical technologies and innovations.

Conclusion

Minoru Kamakura's contributions to pharmaceutical technology through his patents reflect his commitment to improving medication delivery systems. His innovative approaches continue to influence the field and enhance patient experiences.